
Quviviq — daridorexant 50 mg, film-coated tablets, 30 pcs
Brand: Idorsia
+ delivery from €40
Quviviq. Active ingredient — daridorexant, 50 mg. Dosage form — film-coated tablets. Pack size — 30 tablets of 50 mg.
Key information
Full description
Quviviq 50 mg contains daridorexant as the hydrochloride and is available as film-coated tablets. Marketing authorisation holder — Idorsia Pharmaceuticals Spain, S.L., Spain. Daridorexant is an orexin receptor antagonist intended for the treatment of insomnia in adults in line with the approved indications. The medicine is contraindicated in narcolepsy. One tablet contains an amount of daridorexant equivalent to 50 mg of the active ingredient; the pack includes 30 tablets. In moderate hepatic impairment or with concomitant use of moderate CYP3A4 inhibitors, a lower strength may be needed. Before use, refer to the official package leaflet.
Administration
For oral use. The dosing regimen and duration of use are determined by the doctor, taking into account the official package leaflet.
Storage conditions
Store in the original package under the conditions specified by the manufacturer. Keep away from children; read the official package leaflet before use.
Frequently asked questions
What is the active ingredient in Quviviq?
Quviviq contains daridorexant.
What dosage form is Quviviq available in?
Dosage form: Film-coated tablets. Strength: 50 mg.
How much does a pack of Quviviq contain?
The pack shown contains 30 tablets of 50 mg.
How should Quviviq be stored?
Store in the original package under the conditions specified by the manufacturer. Keep away from children; read the official package leaflet before use.
Other strengths and pack sizes
How to order
Tap the button for your preferred messenger. A manager will check availability, confirm the price and ask for your full delivery address.
This information is for reference only. Consult a doctor and read the official package leaflet before use.